COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medicine, Market Insights and Forecast to 2026

Publisher Name :
Date: 29-Jun-2020
No. of pages: 152
Inquire Before Buying

Radiopharmaceuticals in Nuclear Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Radiopharmaceuticals in Nuclear Medicine market is segmented into

- Diagnostic Radiopharmaceuticals

- Therapy Radiopharmaceuticals

- Enriched Stable Isotopes

Segment by Application, the Radiopharmaceuticals in Nuclear Medicine market is segmented into

- Diagnostic Application

- Therapeutic Application

- Research

- Pharmaceutical

- Other

Regional and Country-level Analysis

The Radiopharmaceuticals in Nuclear Medicine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Radiopharmaceuticals in Nuclear Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Radiopharmaceuticals in Nuclear Medicine Market Share Analysis

Radiopharmaceuticals in Nuclear Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiopharmaceuticals in Nuclear Medicine business, the date to enter into the Radiopharmaceuticals in Nuclear Medicine market, Radiopharmaceuticals in Nuclear Medicine product introduction, recent developments, etc.

The major vendors covered:

- Bracco Imaging S.P.A.

- Cambridge Isotope Laboratories, Inc.

- Cardinal Health, Inc.

- Covidien, Plc

- Eczacibasi-Monrol

- Fujifilm Holdings Corporation

- GE Healthcare (Subsidiary Of General Electric Company)

- IBA Group

- Isotec, Inc. (Sigma-Aldrich)

- Lantheus Medical Imaging, Inc.

- Nordion, Inc.

- Ntp Radioisotopes (Pty), Ltd.

- Siemens Healthcare (Subsidiary Of Siemens AG)

- Taiyo Nippon Sanso Corporation

- Urenco Limited

- Rotem Industries, Ltd., Inc.

- Australian Nuclear Association And Technology Organization (ANSTO)

- Board of Radiation And Isotope Technology (BRIT)

- Institute of Atomic Energy Polatom Radioisotope Centre

- Institute of Isotopes Co., Ltd.

- Institute Of Radioelement (IRE)

COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medicine, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction
1.2 Market Segments
1.3 Key Radiopharmaceuticals in Nuclear Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Radiopharmaceuticals in Nuclear Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Radiopharmaceuticals in Nuclear Medicine Industry
1.6.1.1 Radiopharmaceuticals in Nuclear Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Radiopharmaceuticals in Nuclear Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Radiopharmaceuticals in Nuclear Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2015-2026
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2015-2026
2.2 Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Radiopharmaceuticals in Nuclear Medicine Competitor Landscape by Players
3.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2015-2020)
3.1.2 Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medicine Revenue in 2019
3.2.5 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers
3.4 Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (2015-2020)
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2020)
4.1.3 Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application (2015-2020)
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2015-2020)
5.1.3 Radiopharmaceuticals in Nuclear Medicine Price by Application (2015-2020)
5.2 Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Radiopharmaceuticals in Nuclear Medicine by Country
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
6.3 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medicine by Country
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Region
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Radiopharmaceuticals in Nuclear Medicine by Country
9.1.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country
9.1.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
9.3 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Country
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Application
11 Company Profiles
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging S.P.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.2 Cambridge Isotope Laboratories, Inc.
11.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
11.2.2 Cambridge Isotope Laboratories, Inc. Description, Business Overview and Total Revenue
11.2.3 Cambridge Isotope Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
11.3 Cardinal Health, Inc.
11.3.1 Cardinal Health, Inc. Corporation Information
11.3.2 Cardinal Health, Inc. Description, Business Overview and Total Revenue
11.3.3 Cardinal Health, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.3.5 Cardinal Health, Inc. Recent Development
11.4 Covidien, Plc
11.4.1 Covidien, Plc Corporation Information
11.4.2 Covidien, Plc Description, Business Overview and Total Revenue
11.4.3 Covidien, Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered
11.4.5 Covidien, Plc Recent Development
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Corporation Information
11.5.2 Eczacibasi-Monrol Description, Business Overview and Total Revenue
11.5.3 Eczacibasi-Monrol Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered
11.5.5 Eczacibasi-Monrol Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Corporation Information
11.6.2 Fujifilm Holdings Corporation Description, Business Overview and Total Revenue
11.6.3 Fujifilm Holdings Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Description, Business Overview and Total Revenue
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
11.8 IBA Group
11.8.1 IBA Group Corporation Information
11.8.2 IBA Group Description, Business Overview and Total Revenue
11.8.3 IBA Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered
11.8.5 IBA Group Recent Development
11.9 Isotec, Inc. (Sigma-Aldrich)
11.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
11.9.2 Isotec, Inc. (Sigma-Aldrich) Description, Business Overview and Total Revenue
11.9.3 Isotec, Inc. (Sigma-Aldrich) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
11.10 Lantheus Medical Imaging, Inc.
11.10.1 Lantheus Medical Imaging, Inc. Corporation Information
11.10.2 Lantheus Medical Imaging, Inc. Description, Business Overview and Total Revenue
11.10.3 Lantheus Medical Imaging, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.10.5 Lantheus Medical Imaging, Inc. Recent Development
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Corporation Information
11.1.2 Bracco Imaging S.P.A. Description, Business Overview and Total Revenue
11.1.3 Bracco Imaging S.P.A. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.12 Ntp Radioisotopes (Pty), Ltd.
11.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
11.12.2 Ntp Radioisotopes (Pty), Ltd. Description, Business Overview and Total Revenue
11.12.3 Ntp Radioisotopes (Pty), Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ntp Radioisotopes (Pty), Ltd. Products Offered
11.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Development
11.13 Siemens Healthcare (Subsidiary Of Siemens AG)
11.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
11.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Description, Business Overview and Total Revenue
11.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Products Offered
11.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
11.14 Taiyo Nippon Sanso Corporation
11.14.1 Taiyo Nippon Sanso Corporation Corporation Information
11.14.2 Taiyo Nippon Sanso Corporation Description, Business Overview and Total Revenue
11.14.3 Taiyo Nippon Sanso Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Taiyo Nippon Sanso Corporation Products Offered
11.14.5 Taiyo Nippon Sanso Corporation Recent Development
11.15 Urenco Limited
11.15.1 Urenco Limited Corporation Information
11.15.2 Urenco Limited Description, Business Overview and Total Revenue
11.15.3 Urenco Limited Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Urenco Limited Products Offered
11.15.5 Urenco Limited Recent Development
11.16 Rotem Industries, Ltd., Inc.
11.16.1 Rotem Industries, Ltd., Inc. Corporation Information
11.16.2 Rotem Industries, Ltd., Inc. Description, Business Overview and Total Revenue
11.16.3 Rotem Industries, Ltd., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Rotem Industries, Ltd., Inc. Products Offered
11.16.5 Rotem Industries, Ltd., Inc. Recent Development
11.17 Australian Nuclear Association And Technology Organization (ANSTO)
11.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
11.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Description, Business Overview and Total Revenue
11.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Products Offered
11.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
11.18 Board of Radiation And Isotope Technology (BRIT)
11.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
11.18.2 Board of Radiation And Isotope Technology (BRIT) Description, Business Overview and Total Revenue
11.18.3 Board of Radiation And Isotope Technology (BRIT) Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Board of Radiation And Isotope Technology (BRIT) Products Offered
11.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Development
11.19 Institute of Atomic Energy Polatom Radioisotope Centre
11.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
11.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Description, Business Overview and Total Revenue
11.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Products Offered
11.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
11.20 Institute of Isotopes Co., Ltd.
11.20.1 Institute of Isotopes Co., Ltd. Corporation Information
11.20.2 Institute of Isotopes Co., Ltd. Description, Business Overview and Total Revenue
11.20.3 Institute of Isotopes Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Institute of Isotopes Co., Ltd. Products Offered
11.20.5 Institute of Isotopes Co., Ltd. Recent Development
11.21 Institute Of Radioelement (IRE)
11.21.1 Institute Of Radioelement (IRE) Corporation Information
11.21.2 Institute Of Radioelement (IRE) Description, Business Overview and Total Revenue
11.21.3 Institute Of Radioelement (IRE) Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Institute Of Radioelement (IRE) Products Offered
11.21.5 Institute Of Radioelement (IRE) Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Projections by Region
12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.2.2 North America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radiopharmaceuticals in Nuclear Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Radiopharmaceuticals in Nuclear Medicine Market Segments
Table 2. Ranking of Global Top Radiopharmaceuticals in Nuclear Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 5. Major Manufacturers of Therapy Radiopharmaceuticals
Table 6. Major Manufacturers of Enriched Stable Isotopes
Table 7. COVID-19 Impact Global Market: (Four Radiopharmaceuticals in Nuclear Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Radiopharmaceuticals in Nuclear Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Radiopharmaceuticals in Nuclear Medicine Players to Combat Covid-19 Impact
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions 2015-2020 (K MT)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions (2015-2020)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2015-2020)
Table 19. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2019)
Table 21. Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2015-2020) (USD/MT)
Table 24. Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 26. Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2015-2020)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2015-2020)
Table 32. Radiopharmaceuticals in Nuclear Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2015-2020)
Table 35. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 36. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 37. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 39. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 40. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 41. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 42. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 43. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 47. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 49. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 50. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 59. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 60. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 64. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 65. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 66. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2015-2020)
Table 75. Bracco Imaging S.P.A. Corporation Information
Table 76. Bracco Imaging S.P.A. Description and Major Businesses
Table 77. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bracco Imaging S.P.A. Product
Table 79. Bracco Imaging S.P.A. Recent Development
Table 80. Cambridge Isotope Laboratories, Inc. Corporation Information
Table 81. Cambridge Isotope Laboratories, Inc. Description and Major Businesses
Table 82. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cambridge Isotope Laboratories, Inc. Product
Table 84. Cambridge Isotope Laboratories, Inc. Recent Development
Table 85. Cardinal Health, Inc. Corporation Information
Table 86. Cardinal Health, Inc. Description and Major Businesses
Table 87. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Cardinal Health, Inc. Product
Table 89. Cardinal Health, Inc. Recent Development
Table 90. Covidien, Plc Corporation Information
Table 91. Covidien, Plc Description and Major Businesses
Table 92. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Covidien, Plc Product
Table 94. Covidien, Plc Recent Development
Table 95. Eczacibasi-Monrol Corporation Information
Table 96. Eczacibasi-Monrol Description and Major Businesses
Table 97. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Eczacibasi-Monrol Product
Table 99. Eczacibasi-Monrol Recent Development
Table 100. Fujifilm Holdings Corporation Corporation Information
Table 101. Fujifilm Holdings Corporation Description and Major Businesses
Table 102. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Fujifilm Holdings Corporation Product
Table 104. Fujifilm Holdings Corporation Recent Development
Table 105. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 106. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 107. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. GE Healthcare (Subsidiary Of General Electric Company) Product
Table 109. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 110. IBA Group Corporation Information
Table 111. IBA Group Description and Major Businesses
Table 112. IBA Group Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. IBA Group Product
Table 114. IBA Group Recent Development
Table 115. Isotec, Inc. (Sigma-Aldrich) Corporation Information
Table 116. Isotec, Inc. (Sigma-Aldrich) Description and Major Businesses
Table 117. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Isotec, Inc. (Sigma-Aldrich) Product
Table 119. Isotec, Inc. (Sigma-Aldrich) Recent Development
Table 120. Lantheus Medical Imaging, Inc. Corporation Information
Table 121. Lantheus Medical Imaging, Inc. Description and Major Businesses
Table 122. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Lantheus Medical Imaging, Inc. Product
Table 124. Lantheus Medical Imaging, Inc. Recent Development
Table 125. Nordion, Inc. Corporation Information
Table 126. Nordion, Inc. Description and Major Businesses
Table 127. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Nordion, Inc. Product
Table 129. Nordion, Inc. Recent Development
Table 130. Ntp Radioisotopes (Pty), Ltd. Corporation Information
Table 131. Ntp Radioisotopes (Pty), Ltd. Description and Major Businesses
Table 132. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Ntp Radioisotopes (Pty), Ltd. Product
Table 134. Ntp Radioisotopes (Pty), Ltd. Recent Development
Table 135. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
Table 136. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Major Businesses
Table 137. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Siemens Healthcare (Subsidiary Of Siemens AG) Product
Table 139. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
Table 140. Taiyo Nippon Sanso Corporation Corporation Information
Table 141. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 142. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Taiyo Nippon Sanso Corporation Product
Table 144. Taiyo Nippon Sanso Corporation Recent Development
Table 145. Urenco Limited Corporation Information
Table 146. Urenco Limited Des
  • Xanthine Oxidase Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Xanthine Oxidase Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Xanthine Oxidase Inhibitor pipeline landscape is provided, which includes the topic Overview and Xanthine Oxidase Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Xanthine Oxidase Inhibitor commercial assessment and clinical as......
  • Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Wnt Signaling Pathway Inhibitor pipeline landscape is provided, which includes the topic Overview and Wnt Signaling Pathway Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Wnt Signaling Pathway Inhibitor commercial assess......
  • Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Voltage-Gated Sodium Channel Blockers - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Gated Sodium Channel Blockers pipeline landscape is provided, which includes the topic Overview and Voltage-Gated Sodium Channel Blockers mechanism of action. The assessment part of the report embraces, in-depth Voltage-Gated Sodium Channel Bl......
  • Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Dependent T-Type Calcium Channel Blockers pipeline landscape is provided, which includes the topic Overview and Voltage-Dependent T-Type Calcium Channel Blockers mechanism of action. The assessment part of the report embraces, in-d......
  • Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Dependent Calcium Channel Blockers pipeline landscape is provided, which includes the topic Overview and Voltage-Dependent Calcium Channel Blockers mechanism of action. The assessment part of the report embraces, in-depth Voltage-Dependen......
  • Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist pipeline landscape is provided, which includes the topic Overview and Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist mechanism of action. The assessment part of the rep......
  • Viral RNA Polymerase Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Viral RNA Polymerase Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Viral RNA Polymerase Inhibitor pipeline landscape is provided, which includes the topic Overview and Viral RNA Polymerase Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Viral RNA Polymerase Inhibitor commercial assessment......
  • VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor pipeline landscape is provided, which includes the topic Overview and VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor mechanism of......
  • Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Vasopressin V2 Receptor (V2R) Antagonist pipeline landscape is provided, which includes the topic Overview and Vasopressin V2 Receptor (V2R) Antagonist mechanism of action. The assessment part of the report embraces, in-depth Vasopressin V2 Recepto......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs